Exosomes and Exosomal microRNAs in Age-associated Stroke.

Curr Vasc Pharmacol

Department of Neurology, Guangdong Key Laboratory of Age-Related Cardiac and Cerebral Diseases, Affiliated Hospital of Guangdong Medical University, Zhanjiang, 524001, China.

Published: January 2022

Aging has been considered to be the most important non-modifiable risk factor for stroke and death. Changes in circulation factors in the systemic environment, cellular senescence and artery hypertension during human ageing have been investigated. Exosomes are nanosize membrane vesicles that can regulate target cell functions via delivering their carried bioactive molecules (e.g. protein, mRNA, and microRNAs). In the central nervous system, exosomes and exosomal microRNAs play a critical role in regulating neurovascular function and are implicated in stroke initiation and progression. MicroRNAs are small non-coding RNAs that have been reported to play critical roles in various biological processes. Recently, evidence has shown that microRNAs are packaged into exosomes and can be secreted into the systemic and tissue environment. Circulating microRNAs participate in cellular senescence and contribute to age-associated stroke. Here, we provide an overview of current knowledge on exosomes and their carried microRNAs in the regulation of cellular and organismal ageing processes, demonstrating the potential role of exosomes and their carried microRNAs in age-associated stroke.

Download full-text PDF

Source
http://dx.doi.org/10.2174/1570161119666210208202621DOI Listing

Publication Analysis

Top Keywords

age-associated stroke
12
exosomes exosomal
8
micrornas
8
exosomal micrornas
8
micrornas age-associated
8
cellular senescence
8
play critical
8
exosomes carried
8
carried micrornas
8
exosomes
6

Similar Publications

Article Synopsis
  • * Research indicates that older mothers' gut microbiomes negatively impact pregnancy outcomes and offspring behavior, even when young mice are recolonized with the microbiome of older females before pregnancy.
  • * The study found that offspring from these older microbiome recolonized mothers exhibited increased fetal loss, persistent changes in gut microbiome composition, and developed anxiety- and depression-like behaviors, suggesting a link between maternal microbiome changes and neuropsychiatric risks in children.
View Article and Find Full Text PDF

8-Aminopurines: A Promising New Direction for Purine-Based Therapeutics.

Hypertension

December 2024

Department of Pharmacology and Chemical Biology (E.K.J., S.P.T., Y.C., L.A.B.), University of Pittsburgh School of Medicine, Pittsburgh, PA.

Research in purinergic pharmacology has yielded major advances in cardiovascular therapeutics such as adenosine for terminating atrioventricular reentrant tachycardia, regadenoson for pharmacological ischemic stress testing, and selective P2Y receptor antagonists for prevention of stroke and myocardial infarction. Mechanistically, these FDA-approved purine-based therapeutics activate or antagonize receptors having endogenous ligands containing the purine nucleobase adenine. Recent discoveries suggest a novel direction for purine-based therapeutics.

View Article and Find Full Text PDF

Atomic vacancies of molybdenum disulfide nanoparticles stimulate mitochondrial biogenesis.

Nat Commun

September 2024

Department of Biomedical Engineering, College of Engineering, Texas A&M University, College Station, TX, USA.

Diminished mitochondrial function underlies many rare inborn errors of energy metabolism and contributes to more common age-associated metabolic and neurodegenerative disorders. Thus, boosting mitochondrial biogenesis has been proposed as a potential therapeutic approach for these diseases; however, currently we have a limited arsenal of compounds that can stimulate mitochondrial function. In this study, we designed molybdenum disulfide (MoS) nanoflowers with predefined atomic vacancies that are fabricated by self-assembly of individual two-dimensional MoS nanosheets.

View Article and Find Full Text PDF

HOXD12 defines an age-related aggressive subtype of oligodendroglioma.

Acta Neuropathol

September 2024

Neuropathology Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, 10 Center Drive, Building 10/3D17, Bethesda, MD, 20892, USA.

Article Synopsis
  • Oligodendroglioma, particularly the IDH-mutant and 1p/19q-codeleted type, shows varied outcomes based on patient age, with research indicating a bimodal age distribution.
  • Elevated expression and gene body hypermethylation of the HOXD12 gene were identified as significant factors linked to older patient age and shorter survival rates across multiple studies.
  • Analysis revealed that HOXD12 is more active in cancerous tissue and is associated with aggressive tumor characteristics and stem-like cell properties, suggesting it plays a critical role in the progression of oligodendroglioma in older patients.
View Article and Find Full Text PDF

JOURNAL/nrgr/04.03/01300535-202507000-00025/figure1/v/2024-09-09T124005Z/r/image-tiff To investigate the mechanisms underlying the onset and progression of ischemic stroke, some methods have been proposed that can simultaneously monitor and create embolisms in the animal cerebral cortex. However, these methods often require complex systems and the effect of age on cerebral embolism has not been adequately studied, although ischemic stroke is strongly age-related.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!